Paratek Pharmaceuticals Inc. (PRTK)

9.34 -0.04 (-0.426%)

IEX Real-Time Price

October 19, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 9.38

Price Open 9.38

Volume: 508,580

Avg Volume: 977,660

Market Cap: 296.35M

P/E Ratio -2.75

52 Wk Range 8.69-23.5



PRTK Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-09-28
30.43M
7.59M
19.70
24.94%

2018-09-14
30.43M
6.29M
15.07
20.68%

2018-08-31
30.43M
6.94M
10.21
22.80%

2018-08-15
30.43M
6.14M
8.33
20.18%




PRTK Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-02
Q2 2018
AMC
-0.93 (8)
-0.94
-0.01

2018-05-09
Q1 2018
BTO
-0.94 (5)
-0.91
0.03

2018-05-03
Q1 2018
N/A
-0.95 (5)
0.00
0.00

2018-03-01
Q4 2017
N/A
-0.72 (4)
-0.78
-0.06

News

Paratek: No Takeover, But A Theft (2018-10-05 12:30 SeekingAlpha)

No incentive, but a theft Following its day of glory, with two antibiotics approved for a total of three indications, Paratek ( PRTK ) didn't waste any time and immediately adopted a "Revenue Performance Incentive Plan." Incentives are usually a good thing. However, they should be crea…

 

Key events next week - healthcare (2018-10-05 08:59 SeekingAlpha)

Noteworthy events during the week of October 7 - 13 for healthcare investors. More news on: Inspire Medical Systems, Inc., OptiNose, Inc., Paratek Pharmaceuticals, Inc., Healthcare stocks news, , Read more …

 


Statistics

Shares Outstanding: 31.73M

Top 15 Institution Percent: 78.30

Price To Sales: 58.11

Price To Book: 3.48

Revenue: 12000

Gross Profit: N/A

Cash: 33.00M

Debt: N/A

Return On Assets: -39.49

Return On Equity: -101.27

Profit Margin: N/A

Price History

Beta: 0.45

50-day Moving Avg: 9.83

200-day Moving Avg: 11.83

YTD Change: -50.19

5-day Change: 3.66

1-month Change: 2.64

3-month Change: -12.71

6-month Change: -29.51

1-year Change: -60.00

Revenue Per Share: 0.00

Revenue Per Employee: 145.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Paratek Pharmaceuticals Inc.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.paratekpharm.com

Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics based upon tetracycline chemistry.